NDC properties for "Hyrimoz 40 MG per 0.4 ML Auto-Injector" (RxCUI 2641658)
About this data
The tables show NDC propoerties for Hyrimoz 40 MG per 0.4 ML Auto-Injector with the RxCUI 2641658
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Hyrimoz 40 MG per 0.4 ML Auto-Injector (RxCUI 2641658)
| BLA | BLA761071 |
|---|---|
| MMSL_CODE | BD39595 |
| RxCUI | 2641658 |
| SPL_SET_ID | 1ac7d061-3380-468c-b077-c05f8dfbc829 |
| SPL_SET_ID | 3e303a4a-980b-4f2a-9d03-786928758637 |
| Prescribable Synonym | Hyrimoz 40 MG in 0.4 ML Auto-Injector |
| RXNAV_STR | Hyrimoz 40 MG per 0.4 ML Auto-Injector |
| RxNorm Name | 0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector [Hyrimoz] |
| RxNorm Synonym | Hyrimoz 40 MG per 0.4 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2641658) |
NDC Properties
NDC Item 61314047320
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-20 |
| NDC Item | 61314047320 |
| Packaging | 2 SYRINGE in 1 CARTON (61314-473-20) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 61314047377
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-77 |
| NDC Item | 61314047377 |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 61314047392
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-92 |
| NDC Item | 61314047392 |
| Packaging | 2 SYRINGE in 1 CARTON (61314-473-92) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 83457010001
| NDC 9 | 83457-100 |
|---|---|
| NDC 10 | 83457-100-01 |
| NDC Item | 83457010001 |
| Packaging | 2 SYRINGE in 1 CARTON (83457-100-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782641 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-100 |
NDC Item 83457020040
| NDC 9 | 83457-200 |
|---|---|
| NDC 10 | 83457-200-40 |
| NDC Item | 83457020040 |
| Related queries | Properties for NDC 9 83457-200 |
NDC Item 61314047320
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-20 |
| NDC Item | 61314047320 |
| Packaging | 2 SYRINGE in 1 CARTON (61314-473-20) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 61314047377
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-77 |
| NDC Item | 61314047377 |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 61314047392
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-92 |
| NDC Item | 61314047392 |
| Packaging | 2 SYRINGE in 1 CARTON (61314-473-92) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 83457010001
| NDC 9 | 83457-100 |
|---|---|
| NDC 10 | 83457-100-01 |
| NDC Item | 83457010001 |
| Packaging | 2 SYRINGE in 1 CARTON (83457-100-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782641 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-100 |
NDC Item 83457020040
| NDC 9 | 83457-200 |
|---|---|
| NDC 10 | 83457-200-40 |
| NDC Item | 83457020040 |
| Related queries | Properties for NDC 9 83457-200 |
NDC Item 61314047320
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-20 |
| NDC Item | 61314047320 |
| Packaging | 2 SYRINGE in 1 CARTON (61314-473-20) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 61314047377
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-77 |
| NDC Item | 61314047377 |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 61314047392
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-92 |
| NDC Item | 61314047392 |
| Packaging | 2 SYRINGE in 1 CARTON (61314-473-92) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 83457010001
| NDC 9 | 83457-100 |
|---|---|
| NDC 10 | 83457-100-01 |
| NDC Item | 83457010001 |
| Packaging | 2 SYRINGE in 1 CARTON (83457-100-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782641 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-100 |
NDC Item 83457020040
| NDC 9 | 83457-200 |
|---|---|
| NDC 10 | 83457-200-40 |
| NDC Item | 83457020040 |
| Related queries | Properties for NDC 9 83457-200 |
NDC Item 61314047320
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-20 |
| NDC Item | 61314047320 |
| Packaging | 2 SYRINGE in 1 CARTON (61314-473-20) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 61314047377
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-77 |
| NDC Item | 61314047377 |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 61314047392
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-92 |
| NDC Item | 61314047392 |
| Packaging | 2 SYRINGE in 1 CARTON (61314-473-92) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 83457010001
| NDC 9 | 83457-100 |
|---|---|
| NDC 10 | 83457-100-01 |
| NDC Item | 83457010001 |
| Packaging | 2 SYRINGE in 1 CARTON (83457-100-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782641 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-100 |
NDC Item 83457020040
| NDC 9 | 83457-200 |
|---|---|
| NDC 10 | 83457-200-40 |
| NDC Item | 83457020040 |
| Related queries | Properties for NDC 9 83457-200 |
NDC Item 61314047320
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-20 |
| NDC Item | 61314047320 |
| Packaging | 2 SYRINGE in 1 CARTON (61314-473-20) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 61314047377
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-77 |
| NDC Item | 61314047377 |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 61314047392
| NDC 9 | 61314-473 |
|---|---|
| NDC 10 | 61314-473-92 |
| NDC Item | 61314047392 |
| Packaging | 2 SYRINGE in 1 CARTON (61314-473-92) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-473 |
NDC Item 83457010001
| NDC 9 | 83457-100 |
|---|---|
| NDC 10 | 83457-100-01 |
| NDC Item | 83457010001 |
| Packaging | 2 SYRINGE in 1 CARTON (83457-100-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782641 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-100 |
NDC Item 83457020040
| NDC 9 | 83457-200 |
|---|---|
| NDC 10 | 83457-200-40 |
| NDC Item | 83457020040 |
| Related queries | Properties for NDC 9 83457-200 |